Yahoo Web Search

Search results

1. • 

     GoodRx (GDRX) Q1 2024 Earnings Call Transcript

     Motley Fool via Yahoo Finance· 6 days ago

     Third, GoodRx's position within the healthcare value chain details on the strength and durability of our pharmacy network as we focused on rebalancing...

2. • HHS Final Section 1557 Nondiscrimination Regulations: Gender-Affirming Care and the Role of Carriers...

     JD Supra· 7 days ago

     The...

3. • Shopping for health insurance can be eye-opening for college grads, young adults

     Benzinga· 6 days ago

     As college graduates embark on their future, they face a multitude of new decisions, and choosing the right health insurance plan may be one of their most important. "Purchasing health insurance ...

4. • CENTENE SUBSIDIARY SUNFLOWER HEALTH PLAN SELECTED FOR KANSAS MEDICAID AWARD - The Morning Sun

     The Morning Sun· 23 hours ago

     Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that the Kansas Department of Administration ...

5. • 

     Nancy Mace prods Congress to condemn Biden’s plan to extend Obamacare eligibility to noncitizens

     The Washington Times· 7 days ago

     Republicans in Congress are pushing back against a new Biden administration rule that extends health...

6. • CENTENE SUBSIDIARY SUNFLOWER HEALTH PLAN SELECTED FOR KANSAS MEDICAID AWARD

     The Longview News-Journal· 1 day ago

     Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that the Kansas Department of Administration ...

7. • 

     GoodRx Holdings, Inc. (NASDAQ:GDRX) Q1 2024 Earnings Call Transcript

     Insider Monkey via Yahoo Finance· 5 days ago

     GoodRx Holdings, Inc. (NASDAQ:GDRX) Q1 2024 Earnings Call Transcript May 9, 2024 GoodRx Holdings,...

8. • Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition...

     FOX 5 San Diego· 6 days ago

     Celltrion USA announced today that adalimumab-aaty, the company's high-concentration (100 mg/mL) and citrate-free formulation biosimilar to HUMIRA ® (adalimumab), is now available at a low wholesale ...

9. • 

     AG files lawsuit against pharmaceutical companies, pharmacy benefit managers regarding alleged...

     Tulsa World· 1 day ago

     Insulin manufacturers and pharmacy benefit managers have worked together for the last 15 years to...

10. • It’s Raining Regs: CMS Releases Major Laboratory-Developed Test Reg in Midst of Massive Reg Storm |...

      JD Supra· 6 days ago

      Over the last several weeks, the Biden administration has released numerous final regulations in order to “beat the clock” before it ticks down to the Congressional Review Act (CRA) deadline ...